
Ag/Bio & Transgenics
Respresentative Food and Pharmaceutical Clients
|
|
Alza (J&J)
|
|
H.J. Heinz
|
|
|
Bear Creek Corp.
|
|
Johnson & Johnson
|
|
|
Bristol-Myers Squibb
|
|
Merck & Co.
|
|
|
ConAgra
|
|
Molecular Probes
|
|
|
Genemedix
|
|
Penford Foods
|
|
|
Genentech
|
|
Pfizer
|
|
|
Glaxo SmithKline
|
|
Procter & Gamble
|
Value
IDC specializes in design and construction solutions for the
emerging transgenic industry. With many years of experience with
R&D and processing facilities in both food and pharmaceutical
arenas, we have the skills required for project delivery in this
exciting new sector.
In addition to a full complement of planning, design and construction
services, IDC offers expertise in the specialized areas of plant
and animal production and the extraction, purification, and production
of pharmaceutical products.
IDC can assist with prototype, pilot and commercial scale operations;
processing or packaging facility design; project programming, startup
and occupancy; research facility design; equipment selection and
installation; regulatory consulting and compliance; line efficiency
design; procurement; construction management and validation.
IDC understands the unique FDA challenges and requirements facing
emerging technologies, such as protein extraction. We integrate
the regulatory as well as the construction requirements into our
design process. This results in a facility which can be built more
efficiently and is planned for full regulatory compliance. We also
integrate the validation system delivery into the construction program,
which means that validation starts and finishes sooner, saving our
clients valuable time and money.
|